Basilea Pharmaceutica AG (BPMUF)
OTCMKTS · Delayed Price · Currency is USD
67.75
+6.41 (10.45%)
At close: Jul 30, 2025
Basilea Pharmaceutica AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 72.66 | 77.59 | 10.45 | 12.15 | -6.83 | -14.72 | Upgrade |
Depreciation & Amortization | 3.37 | 3.23 | 3.18 | 2.7 | 2.25 | 2.19 | Upgrade |
Other Amortization | 0.9 | 0.9 | 1.74 | 0.66 | 1.3 | 1.3 | Upgrade |
Loss (Gain) From Sale of Assets | - | 1.02 | - | - | -0.07 | -15.04 | Upgrade |
Stock-Based Compensation | 5.39 | 5.07 | 4.76 | 3.6 | 4.32 | 3.53 | Upgrade |
Other Operating Activities | -2.33 | -19.75 | -1.57 | -0.32 | 0.39 | -0.63 | Upgrade |
Change in Accounts Receivable | 11.44 | 19.03 | 5.23 | -8.24 | -16.25 | -2.47 | Upgrade |
Change in Inventory | 8.75 | -5.2 | -2.17 | -1.46 | -1.59 | -2.62 | Upgrade |
Change in Accounts Payable | -1.55 | 5.64 | 5.66 | -10.43 | -2.54 | 6.39 | Upgrade |
Change in Unearned Revenue | 1.75 | 2.31 | -1.23 | -1.23 | -2.56 | -33.63 | Upgrade |
Change in Other Net Operating Assets | -20.88 | -15.48 | -11.8 | 9.64 | -10.45 | 1.56 | Upgrade |
Operating Cash Flow | 79.5 | 74.36 | 14.25 | 7.06 | -32.02 | -54.13 | Upgrade |
Operating Cash Flow Growth | 671.76% | 422.03% | 101.89% | - | - | - | Upgrade |
Capital Expenditures | -1.56 | -1.71 | -0.81 | -3.14 | -0.58 | -1.82 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | 18.33 | Upgrade |
Divestitures | - | 0.78 | - | - | -1.6 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.12 | -0.08 | -0.22 | -0.17 | -0.28 | -0.44 | Upgrade |
Investment in Securities | - | - | - | 94.95 | 6.02 | -51.02 | Upgrade |
Other Investing Activities | - | - | - | 0 | - | - | Upgrade |
Investing Cash Flow | -1.69 | -1.01 | -1.03 | 91.65 | 3.58 | -34.96 | Upgrade |
Long-Term Debt Issued | - | - | - | 73.88 | - | 97.09 | Upgrade |
Long-Term Debt Repaid | - | -15.6 | -59.31 | - | - | - | Upgrade |
Net Debt Issued (Repaid) | - | -15.6 | -59.31 | 73.88 | - | 97.09 | Upgrade |
Issuance of Common Stock | 0.65 | 2.46 | 2.48 | 4.43 | 44.11 | 4.81 | Upgrade |
Repurchase of Common Stock | - | - | - | - | -4.25 | - | Upgrade |
Other Financing Activities | -15.15 | -0.02 | -0.47 | -123.55 | -23.21 | -56.83 | Upgrade |
Financing Cash Flow | -14.49 | -13.16 | -57.31 | -45.25 | 16.64 | 45.07 | Upgrade |
Foreign Exchange Rate Adjustments | -0.07 | 0.05 | -0.15 | 0.16 | 0.5 | -0.76 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade |
Net Cash Flow | 63.25 | 60.24 | -44.25 | 53.61 | -11.3 | -44.79 | Upgrade |
Free Cash Flow | 77.94 | 72.65 | 13.43 | 3.92 | -32.6 | -55.96 | Upgrade |
Free Cash Flow Growth | 734.87% | 440.89% | 242.83% | - | - | - | Upgrade |
Free Cash Flow Margin | 32.99% | 34.84% | 8.52% | 2.65% | -22.01% | -43.84% | Upgrade |
Free Cash Flow Per Share | 5.62 | 5.24 | 1.11 | 0.33 | -2.79 | -5.44 | Upgrade |
Cash Interest Paid | 3.25 | 3.73 | 9.76 | 6.33 | 7.07 | 4.84 | Upgrade |
Cash Income Tax Paid | - | - | 0.01 | 0 | 0.04 | 0.03 | Upgrade |
Levered Free Cash Flow | 53.05 | 48.68 | 8.51 | -2.45 | -25.21 | -46.03 | Upgrade |
Unlevered Free Cash Flow | 54.79 | 50.8 | 14.07 | 3.25 | -21.22 | -42.48 | Upgrade |
Change in Working Capital | -0.49 | 6.29 | -4.32 | -11.72 | -33.39 | -30.76 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.